NCT00574743已完成4 期
A 12-month, Single-blind, Randomized, Parallel Group, Multicenter Study to Investigate the Efficacy and Safety of ERL080A Compared With MMF in de Novo Heart Recipients
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 162
- 试验地点
- 9
研究概览
简要总结
This study will evaluate the safety and efficacy of EC-MPS (ERL080) in comparison to MMF in de novo heart recipients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Active Comparator
干预措施: Enteric-coated Mycophenolate Sodium (Drug)
研究者
研究点 (9)
Loading locations...
相似试验
已完成
4 期
Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant RecipientsDe Novo Kidney Transplant RecipientsNCT00312143Novartis35
Unknown
4 期
Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin InhibitorsOrgan TransplantationNCT00611494University Health Network, Toronto400
招募中
不适用
Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc ResectionBarrett EsophagusBarrett AdenocarcinomaEsophagus NeoplasmNCT03427346Universitätsklinikum Hamburg-Eppendorf407
已完成
3 期
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant RecipientsPatients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPSNCT00238446Novartis Pharmaceuticals
已完成
3 期
Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant RecipientsRenal TransplantationNCT00239070Novartis69